A nomogram for individually predicting the 5-year postoperative recurrence probability in T1 to T2 node negative (T1, 2N0) non-small cell lung cancer
Journal of Clinical Oncology, 2017.
e18534 Background: It is still controversial whether non-small cell lung cancer (NSCLC) patients with pathologically lymph node (LN) negative disease (N0) should receive adjuvant chemotherapy. Some features were considered high risk factors for recurrence in T2 disease and probably in T1 disease. Therefore, we sought to quantify the impac...More
Full Text (Upload PDF)